Amy E. Sobota, MD

Publications

• Published 3/6/2025

  Hildenbrand AK, Mara CA, Murphy B, Hood AM, Johnson Y, Shook LM, Real FJ, Nwankwo C, Hackworth R, Badawy SM, Thompson AA, Raphael JL, Smith-Whitley K, King AA, Calhoun C, Creary SE, Reader SK, Bhasin N, Sobota AE, Houston P, Gipson C, DeBaun MR, Saving KL, Treadwell M, Quinn CT, Crosby LE. Engaging Parents of Children With Sickle Cell Disease in Shared Decision-Making for Hydroxyurea: The ENGAGE-HU Study. Pediatr Blood Cancer. 2025 May; 72(5):e31639. PMID: 40051208.

  Read at: PubMed

• Published 9/25/2024

  Sacta MA, Sarvode S, Kehasse A, Mothi SS, Shah B, Sobota A. Adherence outcomes of a liquid hydroxyurea delivery program in a pediatric population. Pediatr Blood Cancer. 2024 Dec; 71(12):e31348. PMID: 39323047.

  Read at: PubMed

• Published 3/15/2024

  Madrazo-Aguirre K, Ribeil JA, Sobota AE. Initial outcomes in a sickle cell disease transition clinic. Health Care Transit. 2024; 2:100056. PMID: 39712622.

  Read at: PubMed

• Published 1/1/2022

  Lo ZC, Sobota AE. Maintenance of a High Influenza Vaccination Rate and Improvement in Health Outcomes in a Pediatric Sickle Cell Disease Clinic. J Pediatr Hematol Oncol. 2022 01 01; 44(1):e46-e50. PMID: 33974583.

  Read at: PubMed

• Published 12/8/2021

  Slingerland AL, Karsten MB, Smith ER, Sobota AE, See AP. Two Sides of a Coin: Case Report of Unilateral Synangiosis and Contralateral Stroke Highlighting Consequences of Disease Progression and Efficacy of Revascularization in Sickle Cell Disease-Associated Moyamoya Syndrome. Acta Haematol. 2022; 145(4):458-464. PMID: 34879377.

  Read at: PubMed

View All 32 Publications:   View Full Profile in BUMC